Overview


Eric S. Klee focuses his practice on capital markets, including special purpose acquisition companies (SPACs), and mergers & acquisitions transactions. He also routinely advises public companies regarding their reporting and disclosure obligations required by federal securities laws and provides corporate governance advice to public and private companies. Eric represents companies involved in consumer products, OTC pharmaceuticals and medical devices, media and distribution services.

To read Eric’s full biography in Japanese please click here.

Show More

Results


  • Represented Semper Paratus Acquisition Corporation, a special purpose acquisition company, in its US $345 million initial public offering*
  • Represented Sanaby Health Acquisition Corp. I, a special purpose acquisition company, in its US $172.5 million initial public offering*
  • Representing FTAC Emerald Acquisition Corp. in its initial public offering*

Show More

Community


  • New York Bar Association, member

Credentials


Education
Syracuse University College of Law, JD, cum laude, 1997
Tufts University, BA, magna cum laude, 1993

Admissions
New York

Languages
English
Japanese
Spanish